Blocking Enzyme Could Starve Leukemia Cells
Blocking Enzyme Could Starve Leukemia Cells
Blocking Enzyme Could Starve Leukemia Cells
Key points
اہم نکات
मुख्य बातें
- Blocking an enzyme called PTPN2 speeds the breakdown of c-MYC, a protein that drives leukemia cell growth, opening a new target against acute myeloid leukemia.
- Researchers found PTPN2 shields c-MYC from degradation, and an experimental compound that blocks the enzyme slowed leukemia growth in lab tests and in mice.
- The study, published in the journal Targetome, is early-stage work and has not yet been tested in people.
- Blocking an enzyme called PTPN2 speeds the breakdown of c-MYC, a protein that drives leukemia cell growth, opening a new target against acute myeloid leukemia.
- Researchers found PTPN2 shields c-MYC from degradation, and an experimental compound that blocks the enzyme slowed leukemia growth in lab tests and in mice.
- The study, published in the journal Targetome, is early-stage work and has not yet been tested in people.
- Blocking an enzyme called PTPN2 speeds the breakdown of c-MYC, a protein that drives leukemia cell growth, opening a new target against acute myeloid leukemia.
- Researchers found PTPN2 shields c-MYC from degradation, and an experimental compound that blocks the enzyme slowed leukemia growth in lab tests and in mice.
- The study, published in the journal Targetome, is early-stage work and has not yet been tested in people.
Blocking an enzyme called PTPN2 speeds the breakdown of c-MYC, a protein that drives leukemia cell growth, opening a new target against acute myeloid leukemia. Researchers found PTPN2 shields c-MYC from degradation, and an experimental compound that blocks the enzyme slowed leukemia growth in lab tests and in mice. The study, published in the journal Targetome, is early-stage work and has not yet been tested in people.
Blocking an enzyme called PTPN2 speeds the breakdown of c-MYC, a protein that drives leukemia cell growth, opening a new target against acute myeloid leukemia. Researchers found PTPN2 shields c-MYC from degradation, and an experimental compound that blocks the enzyme slowed leukemia growth in lab tests and in mice. The study, published in the journal Targetome, is early-stage work and has not yet been tested in people.
Blocking an enzyme called PTPN2 speeds the breakdown of c-MYC, a protein that drives leukemia cell growth, opening a new target against acute myeloid leukemia. Researchers found PTPN2 shields c-MYC from degradation, and an experimental compound that blocks the enzyme slowed leukemia growth in lab tests and in mice. The study, published in the journal Targetome, is early-stage work and has not yet been tested in people.
Most read
سب سے زیادہ پڑھی گئی
सबसे ज़्यादा पढ़ी गई
- Loading...
Get news in your inbox
خبریں اپنے ان باکس میں حاصل کریں
खबरें अपने इनबॉक्स में पाएं
One email when new stories are published. No spam, unsubscribe anytime.
نئی خبریں شائع ہونے پر ایک ای میل۔ کوئی سپیم نہیں، کسی بھی وقت ان سبسکرائب کریں۔
नई खबरें प्रकाशित होने पर एक ईमेल। कोई स्पैम नहीं, कभी भी अनसब्सक्राइब करें।